As of 2024-12-12, the EV/EBITDA ratio of Novacyt SA (ALNOV.PA) is -0.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALNOV.PA's latest enterprise value is 23.78 mil EUR. ALNOV.PA's TTM EBITDA according to its financial statements is -25.95 mil EUR. Dividing these 2 quantities gives us the above ALNOV.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 13.9x | 9.8x |
| Forward P/E multiples | 10.0x - 16.9x | 12.8x |
| Fair Price | (3.39) - (4.82) | (3.86) |
| Upside | -650.0% - -881.0% | -725.9% |
| Date | EV/EBITDA |
| 2024-11-21 | -0.81 |
| 2024-11-20 | -0.81 |
| 2024-11-19 | -0.85 |
| 2024-11-18 | -0.89 |
| 2024-11-15 | -0.88 |
| 2024-11-14 | -0.94 |
| 2024-11-13 | -0.85 |
| 2024-11-12 | -0.90 |
| 2024-11-11 | -0.92 |
| 2024-11-08 | -0.95 |
| 2024-11-07 | -0.97 |
| 2024-11-06 | -0.99 |
| 2024-11-05 | -1.04 |
| 2024-11-04 | -0.99 |
| 2024-11-01 | -1.05 |
| 2024-10-31 | -1.02 |
| 2024-10-30 | -1.16 |
| 2024-10-29 | -0.94 |
| 2024-10-28 | -1.03 |
| 2024-10-25 | -1.08 |
| 2024-10-24 | -1.04 |
| 2024-10-23 | -1.10 |
| 2024-10-22 | -1.14 |
| 2024-10-21 | -1.03 |
| 2024-10-18 | -1.03 |
| 2024-10-17 | -1.06 |
| 2024-10-16 | -1.03 |
| 2024-10-15 | -1.12 |
| 2024-10-14 | -1.06 |
| 2024-10-11 | -1.06 |
| 2024-10-10 | -1.06 |
| 2024-10-09 | -1.14 |
| 2024-10-08 | -1.12 |
| 2024-10-07 | -1.26 |
| 2024-10-04 | -1.27 |
| 2024-10-03 | -1.24 |
| 2024-10-02 | -1.36 |
| 2024-10-01 | -1.09 |
| 2024-09-30 | -1.03 |
| 2024-09-27 | -1.27 |
| 2024-09-26 | -1.28 |
| 2024-09-25 | -1.50 |
| 2024-09-24 | -1.52 |
| 2024-09-23 | -1.52 |
| 2024-09-20 | -1.54 |
| 2024-09-19 | -1.56 |
| 2024-09-18 | -1.63 |
| 2024-09-17 | -1.68 |
| 2024-09-16 | -1.35 |
| 2024-09-13 | -1.41 |